We served as healthcare regulatory counsel to Parthenon Capital, a growth-oriented private equity firm, in its investment in RxSense, a high-growth healthcare technology company that utilizes its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers. Terms of the transaction were not disclosed.
Parthenon Capital Invests in RxSense
Client Type: Private Company
You Also May Be Interested In:
-
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
-
Representation of Physical Rehabilitation Network (PRN), a privately held physical therapy care provider and comprehensive practice management organization, in its acquisition of three physical therapy clinics in California.
-
Represented Boston Children’s Hospital with intellectual property, business, and government contracting issues associated with VaccineFinder